Open Access

SGLT2i in heart failure

Event: Heart Failure 2021 Online Congress
Topic: Chronic Heart Failure
Session type: Special Session
Date: 29 June 2021
Time: 08:20 - 09:05

Congress Session

This content is currently on OPEN ACCESS

Sign in to view the resources

4 presentations in this session

Mechanism and effect in heart failure.

Speaker: Doctor G. Fragasso (Milan, IT)

Results of SGLT2i trials.

Speaker: Professor G. Filippatos (Athens, GR)

Recommendations for SGLT2i in prevention and treatment.

Speaker: Professor A. Coats (Coventry, GB)

SGLT2i in heart failure - discussion.


3 speakers from this session

Doctor Gabriele Fragasso

, Milan (Italy)
1 presentation
1 follower

Professor Gerasimos Filippatos

National & Kapodistrian University of Athens Medical School, Athens (Greece)
55 presentations
1 follower

Professor Andrew Coats

University of Warwick, Coventry (United Kingdom of Great Britain & Northern Ireland)
91 presentations

Related content

Open Access

SGLT-2 inhibition: Winning battles in heart failure

3 December 2021

Open Access

ESC Guidelines 2021 - Heart Failure

3 December 2021

Open Access

Evolving role of SGLT2i in HFrEF management

3 December 2021

This platform is supported by

logo Novo Nordisk